Antibiotic stewardship in the real world - Authors' reply

Inger van Heijl; Valentijn A Schweitzer; Paul D van der Linden; Cornelis H van Werkhoven; Marc J M Bonten

doi:10.1016/S1473-3099(22)00145-1

Antibiotic stewardship in the real world - Authors' reply

Inger van Heijl
, Valentijn A Schweitzer
, Paul D van der Linden
, Cornelis H van Werkhoven
, Marc J M Bonten

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	449
Number of pages	1
Journal	The Lancet Infectious Diseases
Volume	22
Issue number	4
DOIs	https://doi.org/10.1016/S1473-3099(22)00145-1
Publication status	Published - Apr 2022

Access to Document

10.1016/S1473-3099(22)00145-1

1-s2.0-S1473309922001451-mainFinal published version, 53.2 KBLicence: Taverne

Cite this

@article{92c4a88b007c459eadde9fffe81c87c4,

title = "Antibiotic stewardship in the real world - Authors' reply",

author = "\{van Heijl\}, Inger and Schweitzer, \{Valentijn A\} and \{van der Linden\}, \{Paul D\} and \{van Werkhoven\}, \{Cornelis H\} and Bonten, \{Marc J M\}",

note = "Funding Information: CHvW reports grants from Pfizer, personal fees from Pfizer and MSD/Merck, and non-financial support from BioM{\'e}rieux and DA Volterra, outside the submitted work, and a patent issued for the prediction of clinical manifestations of gut microbiota. All other authors declare no competing interests.",

year = "2022",

month = apr,

doi = "10.1016/S1473-3099(22)00145-1",

language = "English",

volume = "22",

pages = "449",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Antibiotic stewardship in the real world - Authors' reply

AU - van Heijl, Inger

AU - Schweitzer, Valentijn A

AU - van der Linden, Paul D

AU - van Werkhoven, Cornelis H

AU - Bonten, Marc J M

N1 - Funding Information: CHvW reports grants from Pfizer, personal fees from Pfizer and MSD/Merck, and non-financial support from BioMérieux and DA Volterra, outside the submitted work, and a patent issued for the prediction of clinical manifestations of gut microbiota. All other authors declare no competing interests.

PY - 2022/4

Y1 - 2022/4

UR - https://www.scopus.com/pages/publications/85126917829

U2 - 10.1016/S1473-3099(22)00145-1

DO - 10.1016/S1473-3099(22)00145-1

M3 - Letter

C2 - 35338867

SN - 1473-3099

VL - 22

SP - 449

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 4

ER -

Antibiotic stewardship in the real world - Authors' reply

Access to Document

Other files and links

Cite this